View Financial HealthBioceres Crop Solutions 配当と自社株買い配当金 基準チェック /06Bioceres Crop Solutions配当金を支払った記録がありません。主要情報n/a配当利回り-1.6%バイバック利回り総株主利回り-1.6%将来の配当利回りn/a配当成長n/a次回配当支払日n/a配当落ち日n/a一株当たり配当金n/a配当性向n/a最近の配当と自社株買いの更新更新なしすべての更新を表示Recent updatesお知らせ • May 05Bioceres Crop Solutions Corp. to Report Q3, 2026 Results on May 12, 2026Bioceres Crop Solutions Corp. announced that they will report Q3, 2026 results at 12:30 PM, US Eastern Standard Time on May 12, 2026お知らせ • Jan 12Bioceres Crop Solutions Corp., Annual General Meeting, Jan 30, 2026Bioceres Crop Solutions Corp., Annual General Meeting, Jan 30, 2026. Location: 1290 avenue of the americas, ny 10104, new york United Statesお知らせ • Jan 01+ 1 more updateBioceres Crop Solutions Corp. Announces Board and Committee ChangesBioceres Crop Solutions Corp. announced changes to the composition of the board of directors of the Company. Duraiswami ("D") Narain has been appointed as a member of the Board of Directors, effective December 29, 2025. Mr. Narain has served as a non-executive director of RiceTec Inc. since 2025 and as an independent non-executive director of Medi Assist Healthcare Services Ltd. since 2024. Mr. Narain is also a founding partner of AgVaya, an organisation that collaborates with agri businesses, food companies and developmental organizations to create sustainable opportunities and drive growth in smallholder agricultural markets. Mr. Narain served as vice chairman, managing director and chief executive officer of Bayer CropScience Limited from December 2018 to October 2023, and concurrently as president at Bayer South Asia and global head of smallholder farming at Bayer. He previously served as vice president and treasurer of Monsanto Company from November 2015 to October 2018, and held various senior finance and commercial roles at Monsanto from 1998, including chief executive officer of Monsanto's India region. Mr. Narain received an MBA from the Kellogg School of Management at Northwestern University, is a chartered accountant from the Institute of Chartered Accountants of India, and holds a Bachelor of Commerce degree from the University of Madras. Mr. Narain will fill the resulting vacancy and will serve on the committees previously composed by Ms. Zang, including as chair of the audit committee.お知らせ • Oct 31Bioceres Crop Solutions Corp. announced delayed 20-F filingOn 10/30/2025, Bioceres Crop Solutions Corp. announced that they will be unable to file their next 20-F by the deadline required by the SEC.お知らせ • Oct 30Bioceres Crop Solutions Corp. to Report Q1, 2026 Results on Nov 13, 2025Bioceres Crop Solutions Corp. announced that they will report Q1, 2026 results Pre-Market on Nov 13, 2025お知らせ • Oct 02Bioceres Crop Solutions Corp. Announces Resignation of Noah Kolatch as A Member of the Board of Directors, Effective September 30, 2025Bioceres Crop Solutions Corp. informs that, effective September 30, 2025, Noah Kolatch resigned as a member of the board of directors of the Company, in connection with the delivery of the reservation of rights letter delivered to the Company by Jasper Lake, through counsel, dated September 25, 2025, a copy of which is filed herewith as Exhibit 99.1. In response to the Kramer Letter, the Company delivered a reservation of rights letter to Jasper Lake on September 30, 2025, disputing that any Events of Default have occurred under the Note Purchase Agreements and reinforcing that it is in the best interest of the Company and all of its stakeholders to engage in a productive dialogue with Jasper Lake to address any legitimate concern it may have, a copy of which is filed herewith as Exhibit 99.2. The Company is committed to maintaining its focus on improving its commercial and financial performance and delivering innovative solutions to the agricultural market.お知らせ • Sep 03Bioceres Crop Solutions Corp. to Report Q4, 2025 Results on Sep 09, 2025Bioceres Crop Solutions Corp. announced that they will report Q4, 2025 results at 12:30 PM, US Eastern Standard Time on Sep 09, 2025お知らせ • Aug 21Bioceres Crop Solutions Corp. Announces CFO Changes, Effective from August 20, 2025Bioceres Crop Solutions Corp. announced that the board of directors (the “Board”) of the Company and Mr. Enrique Lopez Lecube, Chief Financial Officer, have agreed to initiate a transition in the Company’s financial leadership. Effective August 20, 2025, Mr. Lopez Lecube will step down from his appointment as Chief Financial Officer, and Scott Crocco, a member of the Board, will act solely to assist in managing the finance departments of the Company on an interim basis. The Company has initiated a market search for a new Chief Financial Officer. During his tenure, Mr. Lopez Lecube has made significant contributions to the Company’s financial strategy and expansion.お知らせ • Jun 20Bioceres Crop Solutions Announces Changes to Board of Directors, Effective from June 24, 2025Bioceres Crop Solutions Corp. announced changes to the composition of its Board of Directors. Noah Kolatch and Scott Crocco are being appointed to the Company's Board of Directors with effect from June 24, 2025. Noah Kolatch is a Principal at Jasper Lake LLC, a family investment office that invests across public and private markets. Prior to joining Jasper Lake, Mr. Kolatch was a Partner at Solel Partners, a Boston-based investment firm focused on public equity and credit investments. Mr. Kolatch graduated summa cum laude from Columbia College with a BA in biochemistry. Scott Crocco is a seasoned executive with over three decades of experience in finance and operations across public and private companies. Mr. Crocco was CFO of Air Products & Chemicals Inc, where he led corporate restructuring and portfolio transformation, and later served as Chief Financial Officer of Imperial Dade, a private equity-backed distributor. Mr. Crocco holds a BS in Electrical Engineering from Bucknell University and an MBA from Cornell University. Gloria Montaron Estrada, who has served as a Director since February 2019, and Keith McGovern, who has served as a Non-Executive Director since July 2022, have each resigned from the Company's Board of Directors with effect from June 24, 2025. Enrique Lopez Lecube, the Company's Chief Financial Officer and member of the Company's senior management team, will rotate off the Company's Board of Directors. The resulting vacancy will be filled by Milen Marinov, the Company's Chief Commercial Officer and member of the Company's senior management team. These changes will also be effective from June 24, 2025.お知らせ • May 10Bioceres Crop Solutions Corp. to Report Q3, 2025 Results on May 21, 2025Bioceres Crop Solutions Corp. announced that they will report Q3, 2025 results on May 21, 2025お知らせ • Mar 12Bioceres Crop Solutions and ProFarm Group's Platform, Rinotec, Receives Federal Registration from the U.S. Environmental Protection AgencyBioceres Crop Solutions and ProFarm Group announced that their innovative insecticide and nematicide platform, Rinotec, has received a federal registration from the U.S. Environmental Protection Agency (EPA). Rinotec is exempt from residue tolerance requirements, reflecting the EPA’s assessment of its negligible risk to human health and non-target organisms. Rinotec has already been approved for commercialization in Brazil. With both U.S. and Brazilian registrations now in place, Bioceres Crop Solutions is poised to advance its regulatory and commercial strategies in these regions, offering growers a powerful alternative that reduces reliance on traditional chemical pesticides. These approvals highlight the product’s strong efficacy profile and position Bioceres Crop Solutions to capitalize on growing market opportunities in two of the world’s largest agricultural economies.お知らせ • Mar 06Bioceres Crop Solutions Secures Patent Protection for Hb4 Wheat in the U.S. Until 2042Bioceres Crop Solutions Corp. announced that it has received a Notice of Allowance from the United States Patent and Trademark Office (USPTO) for its first event-specific patent covering the HB4 Wheat, IND-OO412-7. This approval is the first of four potential patents the company is pursuing for HB4 Wheat in the United States, securing protection for this technology and associated production system until 2042. HB4 wheat offers improved tolerance to drought and enhanced weed management options compared to conventional wheat. The technology has already been approved by the USDA for cultivation and by the FDA for food and feed use in the United States. The U.S. is the fourth largest wheat producer, with nearly 40 million acres harvested in the most recent marketing year. In alignment with the company's commitment to responsible commercialization, Bioceres Crop Solutions will adhere to the U.S. Wheat Associates' (USW) "Wheat Industry Principles for Biotechnology Commercialization" developed with the National Association of Wheat Growers (NAWG). These principles include maintaining fluent dialogue with USW/NAWG, securing regulatory approvals for food and feed in major wheat export markets, establishing tolerance thresholds for low level presence, providing trait detection tests, and ensuring product stewardship through education, outreach and a certified seed value capture model. The commercial rollout of HB4 wheat in the U.S. will follow a broad licensing approach, consistent with the company's recently announced go-to-market strategy for its HB4 technology.お知らせ • Feb 06Bioceres Crop Solutions Corp. Provides Earnings Guidance for the Second Quarter Ended December 31, 2024Bioceres Crop Solutions Corp. provided earnings guidance for the second quarter ended December 31, 2024. Second quarter revenues are expected to be approximately $105 million. These results reflect challenging conditions in Argentina, which remains a decisive market for the financial performance of the company in the first half of the year.お知らせ • Jan 30Bioceres Crop Solutions Corp. to Report Q2, 2025 Results on Feb 12, 2025Bioceres Crop Solutions Corp. announced that they will report Q2, 2025 results on Feb 12, 2025お知らせ • Oct 31Bioceres Crop Solutions Corp. to Report Q1, 2025 Results on Nov 12, 2024Bioceres Crop Solutions Corp. announced that they will report Q1, 2025 results on Nov 12, 2024お知らせ • Oct 04Bioceres Crop Solutions Corp., Annual General Meeting, Oct 24, 2024Bioceres Crop Solutions Corp., Annual General Meeting, Oct 24, 2024. Location: 1290 avenue of the americas, new york, 10104, new york United Statesお知らせ • Aug 27Bioceres Crop Solutions Corp. to Report Q4, 2024 Results on Sep 10, 2024Bioceres Crop Solutions Corp. announced that they will report Q4, 2024 results on Sep 10, 2024お知らせ • May 08Bioceres Crop Solutions Corp. Announces Brazil’s Approval of New Generation Bio-InsecticideBioceres Crop Solutions Corp. announced the approval by Brazil’s Ministry of Agriculture and Livestock (MAPA- Ministério da Agricultura e Pecuária) of three new bio-insecticidal/bio-nematicidal solutions derived from inactivated cells of the company’s proprietary Burkholderia platform. The approval represents a significant regulatory milestone in the Brazilian market, marking the first endorsement of biological products formulated from fully inactivated microorganisms. Bioceres’ most advanced bio-control solutions leverage the metabolites of inactivated microorganisms, resulting in products that demonstrate heightened effectiveness, precision, shelf-life, and formulation stability, as well as greater consistency in their mode of action compared to live microbes. Moreover, non-living bacteria-based products can be formulated with increased potency and at much lower costs, nearing cost parity to less favorable present-day chemical alternatives. Bioceres products based on Burkholderia-derived metabolites were first registered in the United States in 2014 and have since been commercialized in Mexico, Peru, Chile, Turkey, and parts of Africa. In the United States alone, they are used as nematicidal and insecticidal seed treatment on more than 4 million hectares (>10 million acres) of corn, cotton and soybeans, effectively replacing abamectin in seed treatments, while also boosting the control of soil-dwelling insect pests that are typically controlled by neonicotinoids, pyrethroids, and organophosphates.お知らせ • May 03Bioceres Crop Solutions Corp. to Report Q3, 2024 Results on May 14, 2024Bioceres Crop Solutions Corp. announced that they will report Q3, 2024 results on May 14, 2024お知らせ • Jan 26Bioceres Crop Solutions Corp. to Report Q2, 2024 Results on Feb 08, 2024Bioceres Crop Solutions Corp. announced that they will report Q2, 2024 results on Feb 08, 2024お知らせ • Nov 01+ 1 more updateBioceres Crop Solutions Corp. to Report Q1, 2024 Results on Nov 14, 2023Bioceres Crop Solutions Corp. announced that they will report Q1, 2024 results on Nov 14, 2023お知らせ • Oct 12Bioceres Crop Solutions Corp., Annual General Meeting, Oct 27, 2023Bioceres Crop Solutions Corp., Annual General Meeting, Oct 27, 2023, at 10:00 US Eastern Standard Time. Location: 1290 Avenue of the Americas New York United States Agenda: To consider the report of the Board of Directors of the Company and the report of the independent auditors of the Company’s consolidated financial statements for the financial year ended June 30, 2023 and to approve the Company’s consolidated financial statements for the financial year ended June 30, 2023; to consider and vote upon a proposal to appoint the seven directors; and to consider and vote upon the ratification of appointment of Price Waterhouse & Co. S.R.L. as the independent registered public accounting firm of the Company.お知らせ • Aug 31Bioceres Crop Solutions Corp. to Report Q4, 2023 Results on Sep 11, 2023Bioceres Crop Solutions Corp. announced that they will report Q4, 2023 results on Sep 11, 2023お知らせ • Jan 27Bioceres Crop Solutions Corp. to Report Q2, 2023 Results on Feb 09, 2023Bioceres Crop Solutions Corp. announced that they will report Q2, 2023 results on Feb 09, 2023決済の安定と成長配当データの取得安定した配当: BIOXDの 1 株当たり配当が過去に安定していたかどうかを判断するにはデータが不十分です。増加する配当: BIOXDの配当金が増加しているかどうかを判断するにはデータが不十分です。配当利回り対市場Bioceres Crop Solutions 配当利回り対市場BIOXD 配当利回りは市場と比べてどうか？セグメント配当利回り会社 (BIOXD)n/a市場下位25% (AR)1.0%市場トップ25% (AR)7.5%業界平均 (Chemicals)3.7%アナリスト予想 (BIOXD) (最長3年)n/a注目すべき配当: BIOXDは最近配当金を報告していないため、配当金支払者の下位 25% に対して同社の配当利回りを評価することはできません。高配当: BIOXDは最近配当金を報告していないため、配当金支払者の上位 25% に対して同社の配当利回りを評価することはできません。株主への利益配当収益カバレッジ: BIOXDの 配当性向 を計算して配当金の支払いが利益で賄われているかどうかを判断するにはデータが不十分です。株主配当金キャッシュフローカバレッジ: BIOXDが配当金を報告していないため、配当金の持続可能性を計算できません。高配当企業の発掘7D1Y7D1Y7D1YAR 市場の強力な配当支払い企業。View Management企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/05/06 11:49終値2026/05/06 00:00収益2025/12/31年間収益2025/06/30データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Bioceres Crop Solutions Corp. 1 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。2 アナリスト機関Brian Kemp DolliverBrookline Capital MarketsAustin MoellerCanaccord Genuity
お知らせ • May 05Bioceres Crop Solutions Corp. to Report Q3, 2026 Results on May 12, 2026Bioceres Crop Solutions Corp. announced that they will report Q3, 2026 results at 12:30 PM, US Eastern Standard Time on May 12, 2026
お知らせ • Jan 12Bioceres Crop Solutions Corp., Annual General Meeting, Jan 30, 2026Bioceres Crop Solutions Corp., Annual General Meeting, Jan 30, 2026. Location: 1290 avenue of the americas, ny 10104, new york United States
お知らせ • Jan 01+ 1 more updateBioceres Crop Solutions Corp. Announces Board and Committee ChangesBioceres Crop Solutions Corp. announced changes to the composition of the board of directors of the Company. Duraiswami ("D") Narain has been appointed as a member of the Board of Directors, effective December 29, 2025. Mr. Narain has served as a non-executive director of RiceTec Inc. since 2025 and as an independent non-executive director of Medi Assist Healthcare Services Ltd. since 2024. Mr. Narain is also a founding partner of AgVaya, an organisation that collaborates with agri businesses, food companies and developmental organizations to create sustainable opportunities and drive growth in smallholder agricultural markets. Mr. Narain served as vice chairman, managing director and chief executive officer of Bayer CropScience Limited from December 2018 to October 2023, and concurrently as president at Bayer South Asia and global head of smallholder farming at Bayer. He previously served as vice president and treasurer of Monsanto Company from November 2015 to October 2018, and held various senior finance and commercial roles at Monsanto from 1998, including chief executive officer of Monsanto's India region. Mr. Narain received an MBA from the Kellogg School of Management at Northwestern University, is a chartered accountant from the Institute of Chartered Accountants of India, and holds a Bachelor of Commerce degree from the University of Madras. Mr. Narain will fill the resulting vacancy and will serve on the committees previously composed by Ms. Zang, including as chair of the audit committee.
お知らせ • Oct 31Bioceres Crop Solutions Corp. announced delayed 20-F filingOn 10/30/2025, Bioceres Crop Solutions Corp. announced that they will be unable to file their next 20-F by the deadline required by the SEC.
お知らせ • Oct 30Bioceres Crop Solutions Corp. to Report Q1, 2026 Results on Nov 13, 2025Bioceres Crop Solutions Corp. announced that they will report Q1, 2026 results Pre-Market on Nov 13, 2025
お知らせ • Oct 02Bioceres Crop Solutions Corp. Announces Resignation of Noah Kolatch as A Member of the Board of Directors, Effective September 30, 2025Bioceres Crop Solutions Corp. informs that, effective September 30, 2025, Noah Kolatch resigned as a member of the board of directors of the Company, in connection with the delivery of the reservation of rights letter delivered to the Company by Jasper Lake, through counsel, dated September 25, 2025, a copy of which is filed herewith as Exhibit 99.1. In response to the Kramer Letter, the Company delivered a reservation of rights letter to Jasper Lake on September 30, 2025, disputing that any Events of Default have occurred under the Note Purchase Agreements and reinforcing that it is in the best interest of the Company and all of its stakeholders to engage in a productive dialogue with Jasper Lake to address any legitimate concern it may have, a copy of which is filed herewith as Exhibit 99.2. The Company is committed to maintaining its focus on improving its commercial and financial performance and delivering innovative solutions to the agricultural market.
お知らせ • Sep 03Bioceres Crop Solutions Corp. to Report Q4, 2025 Results on Sep 09, 2025Bioceres Crop Solutions Corp. announced that they will report Q4, 2025 results at 12:30 PM, US Eastern Standard Time on Sep 09, 2025
お知らせ • Aug 21Bioceres Crop Solutions Corp. Announces CFO Changes, Effective from August 20, 2025Bioceres Crop Solutions Corp. announced that the board of directors (the “Board”) of the Company and Mr. Enrique Lopez Lecube, Chief Financial Officer, have agreed to initiate a transition in the Company’s financial leadership. Effective August 20, 2025, Mr. Lopez Lecube will step down from his appointment as Chief Financial Officer, and Scott Crocco, a member of the Board, will act solely to assist in managing the finance departments of the Company on an interim basis. The Company has initiated a market search for a new Chief Financial Officer. During his tenure, Mr. Lopez Lecube has made significant contributions to the Company’s financial strategy and expansion.
お知らせ • Jun 20Bioceres Crop Solutions Announces Changes to Board of Directors, Effective from June 24, 2025Bioceres Crop Solutions Corp. announced changes to the composition of its Board of Directors. Noah Kolatch and Scott Crocco are being appointed to the Company's Board of Directors with effect from June 24, 2025. Noah Kolatch is a Principal at Jasper Lake LLC, a family investment office that invests across public and private markets. Prior to joining Jasper Lake, Mr. Kolatch was a Partner at Solel Partners, a Boston-based investment firm focused on public equity and credit investments. Mr. Kolatch graduated summa cum laude from Columbia College with a BA in biochemistry. Scott Crocco is a seasoned executive with over three decades of experience in finance and operations across public and private companies. Mr. Crocco was CFO of Air Products & Chemicals Inc, where he led corporate restructuring and portfolio transformation, and later served as Chief Financial Officer of Imperial Dade, a private equity-backed distributor. Mr. Crocco holds a BS in Electrical Engineering from Bucknell University and an MBA from Cornell University. Gloria Montaron Estrada, who has served as a Director since February 2019, and Keith McGovern, who has served as a Non-Executive Director since July 2022, have each resigned from the Company's Board of Directors with effect from June 24, 2025. Enrique Lopez Lecube, the Company's Chief Financial Officer and member of the Company's senior management team, will rotate off the Company's Board of Directors. The resulting vacancy will be filled by Milen Marinov, the Company's Chief Commercial Officer and member of the Company's senior management team. These changes will also be effective from June 24, 2025.
お知らせ • May 10Bioceres Crop Solutions Corp. to Report Q3, 2025 Results on May 21, 2025Bioceres Crop Solutions Corp. announced that they will report Q3, 2025 results on May 21, 2025
お知らせ • Mar 12Bioceres Crop Solutions and ProFarm Group's Platform, Rinotec, Receives Federal Registration from the U.S. Environmental Protection AgencyBioceres Crop Solutions and ProFarm Group announced that their innovative insecticide and nematicide platform, Rinotec, has received a federal registration from the U.S. Environmental Protection Agency (EPA). Rinotec is exempt from residue tolerance requirements, reflecting the EPA’s assessment of its negligible risk to human health and non-target organisms. Rinotec has already been approved for commercialization in Brazil. With both U.S. and Brazilian registrations now in place, Bioceres Crop Solutions is poised to advance its regulatory and commercial strategies in these regions, offering growers a powerful alternative that reduces reliance on traditional chemical pesticides. These approvals highlight the product’s strong efficacy profile and position Bioceres Crop Solutions to capitalize on growing market opportunities in two of the world’s largest agricultural economies.
お知らせ • Mar 06Bioceres Crop Solutions Secures Patent Protection for Hb4 Wheat in the U.S. Until 2042Bioceres Crop Solutions Corp. announced that it has received a Notice of Allowance from the United States Patent and Trademark Office (USPTO) for its first event-specific patent covering the HB4 Wheat, IND-OO412-7. This approval is the first of four potential patents the company is pursuing for HB4 Wheat in the United States, securing protection for this technology and associated production system until 2042. HB4 wheat offers improved tolerance to drought and enhanced weed management options compared to conventional wheat. The technology has already been approved by the USDA for cultivation and by the FDA for food and feed use in the United States. The U.S. is the fourth largest wheat producer, with nearly 40 million acres harvested in the most recent marketing year. In alignment with the company's commitment to responsible commercialization, Bioceres Crop Solutions will adhere to the U.S. Wheat Associates' (USW) "Wheat Industry Principles for Biotechnology Commercialization" developed with the National Association of Wheat Growers (NAWG). These principles include maintaining fluent dialogue with USW/NAWG, securing regulatory approvals for food and feed in major wheat export markets, establishing tolerance thresholds for low level presence, providing trait detection tests, and ensuring product stewardship through education, outreach and a certified seed value capture model. The commercial rollout of HB4 wheat in the U.S. will follow a broad licensing approach, consistent with the company's recently announced go-to-market strategy for its HB4 technology.
お知らせ • Feb 06Bioceres Crop Solutions Corp. Provides Earnings Guidance for the Second Quarter Ended December 31, 2024Bioceres Crop Solutions Corp. provided earnings guidance for the second quarter ended December 31, 2024. Second quarter revenues are expected to be approximately $105 million. These results reflect challenging conditions in Argentina, which remains a decisive market for the financial performance of the company in the first half of the year.
お知らせ • Jan 30Bioceres Crop Solutions Corp. to Report Q2, 2025 Results on Feb 12, 2025Bioceres Crop Solutions Corp. announced that they will report Q2, 2025 results on Feb 12, 2025
お知らせ • Oct 31Bioceres Crop Solutions Corp. to Report Q1, 2025 Results on Nov 12, 2024Bioceres Crop Solutions Corp. announced that they will report Q1, 2025 results on Nov 12, 2024
お知らせ • Oct 04Bioceres Crop Solutions Corp., Annual General Meeting, Oct 24, 2024Bioceres Crop Solutions Corp., Annual General Meeting, Oct 24, 2024. Location: 1290 avenue of the americas, new york, 10104, new york United States
お知らせ • Aug 27Bioceres Crop Solutions Corp. to Report Q4, 2024 Results on Sep 10, 2024Bioceres Crop Solutions Corp. announced that they will report Q4, 2024 results on Sep 10, 2024
お知らせ • May 08Bioceres Crop Solutions Corp. Announces Brazil’s Approval of New Generation Bio-InsecticideBioceres Crop Solutions Corp. announced the approval by Brazil’s Ministry of Agriculture and Livestock (MAPA- Ministério da Agricultura e Pecuária) of three new bio-insecticidal/bio-nematicidal solutions derived from inactivated cells of the company’s proprietary Burkholderia platform. The approval represents a significant regulatory milestone in the Brazilian market, marking the first endorsement of biological products formulated from fully inactivated microorganisms. Bioceres’ most advanced bio-control solutions leverage the metabolites of inactivated microorganisms, resulting in products that demonstrate heightened effectiveness, precision, shelf-life, and formulation stability, as well as greater consistency in their mode of action compared to live microbes. Moreover, non-living bacteria-based products can be formulated with increased potency and at much lower costs, nearing cost parity to less favorable present-day chemical alternatives. Bioceres products based on Burkholderia-derived metabolites were first registered in the United States in 2014 and have since been commercialized in Mexico, Peru, Chile, Turkey, and parts of Africa. In the United States alone, they are used as nematicidal and insecticidal seed treatment on more than 4 million hectares (>10 million acres) of corn, cotton and soybeans, effectively replacing abamectin in seed treatments, while also boosting the control of soil-dwelling insect pests that are typically controlled by neonicotinoids, pyrethroids, and organophosphates.
お知らせ • May 03Bioceres Crop Solutions Corp. to Report Q3, 2024 Results on May 14, 2024Bioceres Crop Solutions Corp. announced that they will report Q3, 2024 results on May 14, 2024
お知らせ • Jan 26Bioceres Crop Solutions Corp. to Report Q2, 2024 Results on Feb 08, 2024Bioceres Crop Solutions Corp. announced that they will report Q2, 2024 results on Feb 08, 2024
お知らせ • Nov 01+ 1 more updateBioceres Crop Solutions Corp. to Report Q1, 2024 Results on Nov 14, 2023Bioceres Crop Solutions Corp. announced that they will report Q1, 2024 results on Nov 14, 2023
お知らせ • Oct 12Bioceres Crop Solutions Corp., Annual General Meeting, Oct 27, 2023Bioceres Crop Solutions Corp., Annual General Meeting, Oct 27, 2023, at 10:00 US Eastern Standard Time. Location: 1290 Avenue of the Americas New York United States Agenda: To consider the report of the Board of Directors of the Company and the report of the independent auditors of the Company’s consolidated financial statements for the financial year ended June 30, 2023 and to approve the Company’s consolidated financial statements for the financial year ended June 30, 2023; to consider and vote upon a proposal to appoint the seven directors; and to consider and vote upon the ratification of appointment of Price Waterhouse & Co. S.R.L. as the independent registered public accounting firm of the Company.
お知らせ • Aug 31Bioceres Crop Solutions Corp. to Report Q4, 2023 Results on Sep 11, 2023Bioceres Crop Solutions Corp. announced that they will report Q4, 2023 results on Sep 11, 2023
お知らせ • Jan 27Bioceres Crop Solutions Corp. to Report Q2, 2023 Results on Feb 09, 2023Bioceres Crop Solutions Corp. announced that they will report Q2, 2023 results on Feb 09, 2023